Head-to-head · free
MaxLinear vs Nebius
MXL vs NBIS — return on capital, cash generation, margins and balance sheet side by side.
MXL
1 / 4
measures where MXL leads
NBIS
3 / 4
measures where NBIS leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | MXL · FY2025 | NBIS |
|---|---|---|
| Revenue | $467.6M | — |
| Net income | (136.7M) | — |
| Revenue growth (yearly, multi-year) | -14.9% | — |
| Free cash flow | $7.0M | — |
| Free cash flow margin | 1.5% | — |
| Net cash / (debt) | — | — |
| ROIC | — | -6.6% |
| Return on equity | -28.2% | 2.1% |
| Gross margin | 56.8% | 68.6% |
| Operating margin | -21.9% | -115.5% |
| Net debt / EBITDA | -0.61x | -3.14x |
Figures are as reported by each company; latest fiscal year shown.
Where MaxLinear's cash went (FY2025)
- Capital spending
- $12.6M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free